Systolic hypertension in older patients: are calcium channel antagonists safe?
The Editor and Associate Editors are pleased that our readership will have the opportunity to benefit from a series of contributions by Dr John Rutherford addressing current issues in pharmacology and therapeutics pertinent to coronary artery disease. We are pleased also that Dr Rutherford will provide authoritative perspectives on topics of immediate interest on a regular basis.
Rutherford
J D
JD
Division of Cardiology, University of Texas Southwestern Medical Center, Dallas 75390-9047, USA. John.Rutherford@UTSouthwestern.edu
D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008875:Middle Aged
D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers